Nuvilex CEO购买了70,000股,花费56,600美元,将股份增加到346,250股。 Nuvilex CEO bought 70,000 shares Jan. 5–7, spending $56,600, boosting his stake to 346,250 shares.

Nuvilex CEO Joshua Silverman于2026年1月5日和7日购买了70,000股股票,共支出56,600美元,股份增加了9.5%,达到346,250股,价值约270,000美元。 Nuvilex CEO Joshua Silverman bought 70,000 shares on January 5 and 7, 2026, spending $56,600 total, increasing his stake by about 9.5% to 346,250 shares, valued at roughly $270,000. 这些采购在证交会档案中披露。 The purchases were disclosed in an SEC filing. 1月7日,库存以0.83美元关闭,增加了0.06美元,数额高于平均数额。 The stock closed at $0.83 on January 7, up $0.06, with above-average volume. Nuvilex的市场上限为841万美元,在2025年12月18日截止的季度中,每股损失0.32美元,并持有分析员和市场部的“销售”评级。 Nuvilex has a market cap of $8.41 million, reported a $0.32 per share loss for the quarter ending December 18, 2025, and holds a “sell” rating from analysts and MarketBeat. 该公司利用其 " 生物细胞 " 技术开发癌症疗法。 The company develops cancer therapies using its Cell-in-a-Box technology.